FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity

Molecular and Cellular Biology

Volumn 26, Issue 9, 2006, Pages 3455-3467

  Wu, Qiwei ^b   Ortegon, Angelica M ^a   Tsang, Bernice ^a   Doege, Holger ^b   Feingold, Kenneth R ^c   Stahl, Andreas ^a,b  

^a PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; FATTY ACID TRANSPORT PROTEIN 1; INSULIN; LONG CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ADIPOCYTE; ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DIET; DIET INDUCED OBESITY; FAT INTAKE; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; HORMONAL REGULATION; INSULIN RESISTANCE; INSULIN SENSITIVE TISSUE; INSULIN SENSITIVITY; INTRACELLULAR TRANSPORT; KNOCKOUT GENE; LIVER; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; NULL ALLELE; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN TRANSPORT; SKELETAL MUSCLE; TISSUE; TISSUE DISTRIBUTION;

ADIPOCYTES; ANIMALS; BIOLOGICAL TRANSPORT; DIETARY FATS, UNSATURATED; FATTY ACID TRANSPORT PROTEINS; FATTY ACIDS, UNSATURATED; INSULIN; LIVER; METABOLIC SYNDROME X; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; OBESITY;

ANIMALIA;

EID: 33646239182     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.26.9.3455-3467.2006     Document Type: Article

References (58)

1. Abel, E. D., O. Peroni, J. K. Kim, Y. B. Kim, O. Boss, E. Hadro, T. Minnemann, G. I. Shulman, and B. B. Kahn. 2001. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409:729-733.
2. Abumrad, N., C. Coburn, and A. Ibrahimi. 1999. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim. Biophys. Acta 1441:4-13.
3. Abumrad, N., C. Harmon, and A. Ibrahimi. 1998. Membrane transport of long-chain fatty acids: evidence for a facilitated process. J. Lipid Res. 39:2309-2318.
4. Augustus, A., H. Yagyu, G. Haemmerle, A. Bensadoun, R. K. Vikramadithyan, S. Y. Park, J. K. Kim, R. Zechner, and I. J. Goldberg. 2004. Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression. J. Biol. Chem. 279:25050-25057.
5. Binnert, C., H. A. Koistinen, G. Martin, F. Andreelli, P. Ebeling, V. A. Koivisto, M. Laville, J. Auwerx, and H. Vidal. 2000. Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humans. Am. J. Physiol. Endocrinol. Metab. 279:E1072-E1079.
6. Boden, G. 1997. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10.
7. Bonen, A., J. Luiken, Y. Arumugam, J. Glatz, and N. Tandon. 2000. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J. Biol. Chem. 275:14501-14508.
8. Carley, A. N., L. M. Semeniuk, Y. Shimoni, E. Aasum, T. S. Larsen, J. P. Berger, and D. L. Severson. 2004. Treatment of type 2 diabetic db/db mice with a novel PPARγ agonist improves cardiac metabolism but not contractile function. Am. J. Physiol. Endocrinol. Metab. 286:E449-E455.
9. Chiu, H. C., A. Kovacs, D. A. Ford, F. F. Hsu, R. Garcia, P. Herrero, J. E. Saffitz, and J. E. Schaffer. 2001. A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Investig. 107:813-822.
10. Coburn, C. T., T. Hajri, A. Ibrahimi, and N. A. Abumrad. 2001. Role of CD36 in membrane transport and utilization of long-chain fatty acids by different tissues. J. Mol. Neurosci. 16:117-121.
11. Coburn, C. T., F. F. Knapp, Jr., M. Febbraio, A. L. Beets, R. L. Silverstein, and N. A. Abumrad. 2000. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem. 275:32523-32529.
12. Coe, N., A. Smith, B. Frohnert, P. Watkins, and D. Bernlohr. 1999. The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase. J. Biol. Chem. 274:36300-36304.
13. Cushman, S. W., L. J. Goodyear, P. F. Pilch, E. Ralston, H. Galbo, T. Ploug, S. Kristiansen, and A. Klip. 1998. Molecular mechanisms involved in GLUT4 translocation in muscle during insulin and contraction stimulation. Adv. Exp. Med. Biol. 441:63-71.
14. Duncia, J. V., J. B. Santella III, C. A. Higley, W. J. Pitts, J. Wityak, W. E. Frietze, F. W. Rankin, J. H. Sun, R. A. Earl, A. C. Tabaka, C. A. Teleha, K. F. Blom, M. F. Favata, E. J. Manos, A. J. Daulerio, D. A. Stradley, K. Horiuchi, R. A. Copeland, P. A. Scherle, J. M. Trzaskos, R. L. Magolda, G. L. Trainor, R. R. Wexler, F. W. Hobbs, and R. E. Olson. 1998. MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg. Med. Chem. Lett. 8:2839-2844.
15. Febbraio, M., N. A. Abumrad, D. P. Hajjar, K. Sharma, W. Cheng, S. F. Pearce, and R. L. Silverstein. 1999. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 274:19055-19062.
16. Febbraio, M., D. P. Hajjar, and R. L. Silverstein. 2001. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Investig. 108:785-791.
17. Gimeno, R. E., D. J. Hirsch, S. Punreddy, Y. Sun, A. M. Ortegon, H. Wu, T. Daniels, A. Stricker-Krongrad, H. F. Lodish, and A. Stahl. 2003. Targeted deletion of fatty acid transport protein-4 results in early embryonic lethality. J. Biol. Chem. 278:49512-49516.
18. Gimeno, R. E., A. M. Ortegon, S. Patel, S. Punreddy, P. Ge, Y. Sun, H. F. Lodish, and A. Stahl. 2003. Characterization of a heart-specific fatty acid transport protein. J. Biol. Chem. 278:16039-16044.
19. Gore, J., and C. Hoinard. 1993. Linolenic acid transport in hamster intestinal cells is carrier-mediated. J. Nutr. 123:66-73.
20. Hajri, T., X. X. Han, A. Bonen, and N. A. Abumrad. 2002. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J. Clin. Investig. 109:1381-1389.
21. Hamilton, J. A. 1999. Transport of fatty acids across membranes by the diffusion process. Prostaglandins Leukot. Essent. Fatty Acids 60:291-297.
22. Hanke, J. H., J. P. Gardner, R. L. Dow, P. S. Changelian, W. H. Brissette, E. J. Weringer, B. A. Pollok, and P. A. Connelly. 1996. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271:695-701.
23. Hensley, L. L., G. Ranganathan, E. M. Wagner, B. D. Wells, J. C. Daniel, D. Vu, C. F. Semenkovich, R. Zechner, and P. A. Kern. 2003. Transgenic mice expressing lipoprotein lipase in adipose tissue. Absence of the proximal 3′-untranslated region causes translational upregulation. J. Biol. Chem. 278:32702-32709.
24. Hirsch, D., A. Stahl, and H. F. Lodish. 1998. A family of fatty acid transporters conserved from mycobacterium to man. Proc. Natl. Acad. Sci. USA 95:8625-8629.
25. Holm, C., T. Osterlund, H. Laurell, and J. A. Contreras. 2000. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu. Rev. Nutr. 20:365-393.
26. Jacobson, P. B., S. L. Kuchera, A. Metz, C. Schachtele, K. Imre, and D. J. Schrier. 1995. Anti-inflammatory properties of Go 6850: a selective inhibitor of protein kinase C. J. Pharmacol. Exp. Ther. 275:995-1002.
27. Kim, J. K., J. J. Fillmore, Y. Chen, C. Yu, I. K. Moore, M. Pypaert, E. P. Lutz, Y. Kako, W. Velez-Carrasco, I. J. Goldberg, J. L. Breslow, and G. I. Shulman. 2001. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. USA 98:7522-7527.
28. Kim, J. K., R. E. Gimeno, T. Higashimori, H. J. Kim, H. Choi, S. Punreddy, R. L. Mozell, G. Tan, A. Stricker-Krongrad, D. J. Hirsch, J. J. Fillmore, Z. X. Liu, J. Dong, G. Cline, A. Stahl, H. F. Lodish, and G. I. Shulman. 2004. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J. Clin. Investig. 113:756-763.
29. Lawrence, D. S., and J. Niu. 1998. Protein kinase inhibitors: the tyrosine-specific protein kinases. Pharmacol. Ther. 77:81-114.
30. Lee, C. H., P. Olson, and R. M. Evans. 2003. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144:2201-2207.
31. Levak-Frank, S., H. Radner, A. Walsh, R. Stollberger, G. Knipping, G. Hoefler, W. Sattler, P. H. Weinstock, J. L. Breslow, and R. Zechner. 1995. Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J. Clin. Investig. 96:976-986.
32. Luiken, J. J., D. J. Dyck, X. X. Han, N. N. Tandon, Y. Arumugam, J. F. Glatz, and A. Bonen. 2002. Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane. Am. J. Physiol. Endocrinol. Metab. 282:E491-E495.
33. Masuzaki, H., J. Paterson, H. Shinyama, N. M. Morton, J. J. Mullins, J. R. Seckl, and J. S. Flier. 2001. A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170.
34. Novac, O., A. S. Guenier, and J. Pelletier. 2004. Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen. Nucleic Acids Res. 32:902-915.
35. Powis, G., R. Bonjouklian, M. M. Berggren, A. Gallegos, R. Abraham, C. Ashendel, L. Zalkow, W. F. Matter, J. Dodge, G. Grindey, et al. 1994. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 54:2419-2423.
36. Reaven, G. M., C. Hollenbeck, C. Y. Jeng, M. S. Wu, and Y. D. Chen. 1988. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024.
37. Richieri, G. V., and A. M. Kleinfeld. 1995. Unbound free fatty acid levels in human serum. J. Lipid Res. 36:229-240.
38. Rosenzweig, T., S. Aga-Mizrachi, A. Bak, and S. R. Sampson. 2004. SrC tyrosine kinase regulates insulin-induced activation of protein kinase C (PKC) delta in skeletal muscle. Cell. Signal. 16:1299-1308.
39. Schaffer, J. E., and H. F. Lodish. 1994. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79:427-436.
40. Schmitz-Peiffer, C. 2000. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell. Signal. 12:583-594.
41. Shulman, G. I. 2000. Cellular mechanisms of insulin resistance. J. Clin. Investig. 106:171-176.
42. Sorrentino, D., D. Stump, B. J. Potter, R. B. Robinson, R. White, C. L. Kiang, and P. D. Berk. 1988. Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut. J. Clin. Investig. 82:928-935.
43. Stahl, A. 2004. A current review of fatty acid transport proteins (SLC27). Pflugers Arch. 447:722-727.
44. Stahl, A., J. G. Evans, S. Pattel, D. Hirsch, and H. F. Lodish. 2002. Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes. Dev. Cell 2:477-488.
45. Stahl, A., D. J. Hirsch, R. Gimeno, S. Punreddy, P. Ge, N. Watson, M. Kotler, L. A. Tartaglia, and H. F. Lodish. 1999. Identification of a small intestinal fatty acid transport protein. Mol. Cell 4:299-308.
46. Steiner, G., S. Morita, and M. Vranic. 1980. Resistance to insulin but not to glucagon in lean human hypertriglyceridemics. Diabetes 29:899-905.
47. Steneberg, P., N. Rubins, R. Bartoov-Shiftnan, M. D. Walker, and H. Edlund. 2005. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab. 1:245-258.
48. Stiles, B., Y. Wang, A. Stahl, S. Bassilian, W. P. Lee, Y. J. Kim, R. Sherwin, S. Devaskar, R. Lesche, M. A. Magnuson, and H. Wu. 2004. Live-specific deletion of negative regulator Pten results in fatty liver and insulin hyper-sensitivity. Proc. Natl. Acad. Sci. USA 101:2082-2087.
49. Stremmel, W. 1989. Mechanism of hepatic fatty acid uptake. J. Hepatol. 9:374-382.
50. Stremmel, W. 1989. Transmembrane transport of fatty acids in the heart. Mol. Cell. Biochem. 88:23-29.
51. Stremmel, W. 1988. Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein. J. Clin. Investig. 82:2001-2010.
52. Stump, D. D., X. Fan, and P. D. Berk. 2001. Oleic acid uptake and binding by rat adipocytes define dual pathways for cellular fatty acid uptake. J. Lipid Res. 42:509-520.
53. Tremblay, F., M. J. Dubois, and A. Marette. 2003. Regulation of GLUT4 traffic and function by insulin and contraction in skeletal muscle. Front. Biosci. 8:dl072-dl084.
54. Vistisen, B., K. Roepstorff, C. Roepstorff, A. Bonen, B. van Deurs, and B. Kiens. 2004. Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers. J. Lipid Res. 45:603-609.
55. Weyer, C., J. E. Foley, C. Bogardus, P. A. Tataranni, and R. E. Pratley. 2000. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43:1498-1506.
56. Yagyu, H., G. Chen, M. Yokoyama, K. Hirata, A. Augustus, Y. Kako, T. Seo, Y. Hu, E. P. Lutz, M. Merkel, A. Bensadoun, S. Homma, and I. J. Goldberg. 2003. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J. Clin. Investig. 111:419-426.
57. Yang, L., H. C. Dan, M. Sun, Q. Liu, X. M. Sun, R. I. Feldman, A. D. Hamilton, M. Polokoff, S. V. Nicosia, M. Herlyn, S. M. Sebti, and J. Q. Cheng. 2004. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res. 64:4394-4399.
58. Zou, Z., C. C. DiRusso, V. Ctrnacta, and P. N. Black. 2002. Fatty acid transport in Saccharomyces cerevisiae. Directed mutagenesis of FAT1 distinguishes the biochemical activities associated with Fatlp. J. Biol. Chem. 277:31062-31071.